This work is licensed under the Creative Commons Attribution 4.0 International License.
Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, et al. Salivary Gland Hypofunction/Xerostomia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/ International Society of Oral Oncology (ISOO). A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer 2010; 18: 1039-60. 10.1007/s00520-010-0827-8JensenSBPedersenAMVissinkAAndersenEBrownCGDaviesANSalivary Gland Hypofunction/Xerostomia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of lifeSupport Care Cancer20101810396010.1007/s00520-010-0827-8Open DOISearch in Google Scholar
Mandel SJ, Mandel L. Radioactive iodine and the salivary glands. Thyroid 2003; 13: 265-71. 10.1089/105072503321582060MandelSJMandelLRadioactive iodine and the salivary glandsThyroid2003132657110.1089/105072503321582060Open DOISearch in Google Scholar
Fard-Esfahani A, Emami-Ardekani A, Fallahi B, Fard-Esfahani P, Beiki D, Hassanzadeh-Rad A, et al. Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma. Nucl Med Commun 2014; 35: 808-17. 10.1097/MNM.0000000000000132Fard-EsfahaniAEmami-ArdekaniAFallahiBFard-EsfahaniPBeikiDHassanzadeh-RadAAdverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinomaNucl Med Commun2014358081710.1097/MNM.0000000000000132Open DOISearch in Google Scholar
Jeong SY, Kim HW, Lee SW, AhnBC, Lee J. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms. Thyroid 2013; 23: 609-16. 10.1089/thy.2012.0106JeongSYKimHWLeeSWAhnBCLeeJSalivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptomsThyroid2013236091610.1089/thy.2012.0106Open DOISearch in Google Scholar
Bohuslavizki KH, Klutmann S, Jenicke L, Kröger S, Buchert R, Mester J, et al. Salivary gland protection by S-2-(3-aminopropylamino)-ethylphosphorothioic acid (amifostine) in high-dose radioiodine treatment: results obtained in a rabbit animal model and in a double-blind multi-arm trial. Cancer Biother Radiopharm 1999; 14: 337-47. 10.1089/cbr.1999.14.337BohuslavizkiKHKlutmannSJenickeLKrögerSBuchertRMesterJSalivary gland protection by S-2-(3-aminopropylamino)-ethylphosphorothioic acid (amifostine) in high-dose radioiodine treatment: results obtained in a rabbit animal model and in a double-blind multi-arm trialCancer Biother Radiopharm1999143374710.1089/cbr.1999.14.337Open DOISearch in Google Scholar
Joseph LJ, Bhartiya US, Raut YS, Hawaldar RW, Nayak Y, Pawar YP, et al. Radioprotective effect of Ocimum sanctum and amifostine on the salivary gland of rats after therapeutic radioiodine exposure. Cancer Biother Radiopharm 2011; 26: 737-43. 10.1089/cbr.2011.1014JosephLJBhartiyaUSRautYSHawaldarRWNayakYPawarYPRadioprotective effect of Ocimum sanctum and amifostine on the salivary gland of rats after therapeutic radioiodine exposureCancer Biother Radiopharm2001267374310.1089/cbr.2011.1014Open DOISearch in Google Scholar
Sagowski C, Wenzel S, Metternich FU, Kehrl W. Studies on the radioprotective potency of amifostine on salivary glands of rats during fractionated irradiation: acute and late effects. Eur Arch Otorhinolaryngol 2003; 260: 42-7. 10.1007/s00405-002-0496-4SagowskiCWenzelSMetternichFUKehrlWStudies on the radioprotective potency of amifostine on salivary glands of rats during fractionated irradiation: acute and late effectsEur Arch Otorhinolaryngol200326042710.1007/s00405-002-0496-4Open DOISearch in Google Scholar
Pimentel MJ, Filho MM, Araújo M, Gomes DQ, DA Costa LJ. Evaluation of radioprotective effect of pilocarpine ingestion on salivary glands. Anticancer Res 2014; 34: 1993-9.PimentelMJFilhoMMAraújoMGomesDQDA CostaLJEvaluation of radioprotective effect of pilocarpine ingestion on salivary glandsAnticancer Res20143419939Search in Google Scholar
Koca G, Gültekin SS, Han U, Kuru S, Demirel K, Korkmaz M. The efficacy of montelukast as a protective agent against 131I-induced salivary gland damage in rats: scintigraphic and histopathological findings. Nucl Med Commun 2013; 34: 507-17. 10.1097/MNM.0b013e32835ffecdKocaGGültekinSSHanUKuruSDemirelKKorkmazMThe efficacy of montelukast as a protective agent against 131I-induced salivary gland damage in rats: scintigraphic and histopathological findingsNucl Med Commun2013345071710.1097/MNM.0b013e32835ffecdOpen DOISearch in Google Scholar
Hamlar DD, Schuller DE, Gahbauer RA, Buerki RA, Staubus AE, Hall J, et al. Determination of the efficacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinoma. Laryngoscope 1996; 106: 972-6.HamlarDDSchullerDEGahbauerRABuerkiRAStaubusAEHallJDetermination of the efficacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinomaLaryngoscope19961069726Search in Google Scholar
Ding DC, Chang YH, Shyu WC, Lin SZ. Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy. Cell Transplant 2015; 24: 339-47. 10.3727/096368915X686841DingDCChangYHShyuWCLinSZHuman umbilical cord mesenchymal stem cells: a new era for stem cell therapyCell Transplant2015243394710.3727/096368915X686841Open DOISearch in Google Scholar
Ramdasi S, Sarang S, Viswanathan C. Potential of mesenchymal stem cell based application in cancer. Int J HematolOncol Stem Cell Res 2015; 9: 95-103.RamdasiSSarangSViswanathanC Potential of mesenchymal stem cell based application in cancerInt J HematolOncol Stem Cell Res2015995103Search in Google Scholar
Luo CJ, Zhang FJ, Zhang L, Geng YQ, Li QG, Hong Q, et al. Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice. Shock 2014; 41: 123-129. 10.1097/SHK.0000000000000080LuoCJZhangFJZhangLGengYQLiQGHongQMesenchymal stem cells ameliorate sepsis-associated acute kidney injury in miceShock20144112312910.1097/SHK.0000000000000080Open DOISearch in Google Scholar
Weil BR, Manukyan MC, Herrmann JL, Wang Y, Abarbanell AM, Poynter JA, et al. Mesenchymal stem cells attenuate myocardial functional depression and reduce systemic and myocardial inflammation during endotoxemia. Surgery 2010; 148: 444-52. 10.1016/j.surg.2010.03.010WeilBRManukyanMCHerrmannJLWangYAbarbanellAMPoynterJAMesenchymal stem cells attenuate myocardial functional depression and reduce systemic and myocardial inflammation during endotoxemiaSurgery20101484445210.1016/j.surg.2010.03.010Open DOISearch in Google Scholar
Lombaert IM, Wierenga PK, Kok T, Kampinga HH, deHaan G, Coppes RP. Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glands. Clin Cancer Res 2006; 12: 1804-12. 10.1158/1078-0432.CCR-05-2381LombaertIMWierengaPKKokTKampingaHHdeHaanGCoppesRMobilization of bone marrow stem cells by granulocyte colony-stimulating factor ameliorates radiation-induced damage to salivary glandsClin Cancer Res20061218041210.1158/1078-0432.CCR-05-2381Open DOISearch in Google Scholar
Jeong J, Baek H, Kim YJ, Choi Y, Lee H, Lee E, et al. Human salivary gland stem cells ameliorate hyposalivation of radiation-damaged rat salivary glands. Exp Mol Med 2013; 45: e58. 10.1038/emm.2013.121JeongJBaekHKimYJChoiYLeeHLeeEHuman salivary gland stem cells ameliorate hyposalivation of radiation-damaged rat salivary glandsExp Mol Med201345e5810.1038/emm.2013.121Open DOISearch in Google Scholar
Fried SK, Moustaid-Moussa N. Culture of adipose tissue and isolated adipocytes. Methods Mol Biol 2001; 155: 197-212. 10.1385/1-59259-231-7:197FriedSKMoustaid-MoussaNCulture of adipose tissue and isolated adipocytesMethods Mol Biol200115519721210.1385/1-59259-231-7:197Open DOISearch in Google Scholar
Alexander C, Bader JB, Schaefer A, Finke C, Kirsch CM. Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma. J Nucl Med 1998; 39: 1551-4.AlexanderCBaderJBSchaeferAFinkeCKirschCMIntermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinomaJ Nucl Med19983915514Search in Google Scholar
Solans R, Bosch JA, Galofré P, Porta F, Roselló J, Selva-O’Callagan A, et al. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med 2001; 42: 738-43.SolansRBoschJAGalofréPPortaFRosellóJSelva-O’CallaganASalivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapyJ Nucl Med20014273843Search in Google Scholar
Wei X, Yang X, Han ZP, Qu FF, Shao L, Shi YF. Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin 2013; 34: 747-54. 10.1038/aps.2013.50WeiXYangXHanZPQuFFShaoLShiYFMesenchymal stem cells: a new trend for cell therapyActa Pharmacol Sin2013347475410.1038/aps.2013.50Open DOISearch in Google Scholar
Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, et al. International Society for Cellular Therapy. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005; 7: 393-5. 10.1080/14653240500319234HorwitzEMLe BlancKDominiciMMuellerISlaper-CortenbachIMariniFCInternational Society for Cellular Therapy. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statementCytotherapy20057393510.1080/14653240500319234Open DOISearch in Google Scholar
Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT, et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010; 7: 521-31. 10.1016/j.stem.2010.07.017MaysharYBen-DavidULavonNBiancottiJCYakirBClarkATIdentification and classification of chromosomal aberrations in human induced pluripotent stem cellsCell Stem Cell201075213110.1016/j.stem.2010.07.017Open DOISearch in Google Scholar
Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279-95. 10.1091/mbc.E02-02-0105ZukPAZhuMAshjianPDe UgarteDAHuangJIMizunoHHuman adipose tissue is a source of multipotent stem cellsMol Biol Cell20021342799510.1091/mbc.E02-02-0105Open DOISearch in Google Scholar
Salibian AA, Widgerow AD, Abrouk M, Evans GR. Stem cells in plastic surgery: a review of current clinical and translational applications. Arch Plast Surg 2013; 40: 666-75. 10.5999/aps.2013.40.6.666SalibianAAWidgerowADAbroukMEvansGRStem cells in plastic surgery: a review of current clinical and translational applicationsArch Plast Surg2013406667510.5999/aps.2013.40.6.666Open DOISearch in Google Scholar
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7: 211-28. 10.1089/107632701300062859ZukPAZhuMMizunoHHuangJFutrellJWKatzAJMultilineage cells from human adipose tissue: implications for cell-based therapiesTissue Eng200172112810.1089/107632701300062859Open DOISearch in Google Scholar
Brayfield C, Marra K, Rubin JP. Adipose stem cells for soft tissue regeneration. Handchir Mikrochir Plast Chir 2010; 42: 124-8. 10.1055/s-0030-1248269BrayfieldCMarraKRubinJPAdipose stem cells for soft tissue regenerationHandchir Mikrochir Plast Chir201042124810.1055/s-0030-1248269Open DOISearch in Google Scholar
Lim JY, Ra JC, Shin IS, Jang YH, An HY, Choi JS, et al. Systemic transplantation of human adipose tissue-derived mesenchymal stem cells for the regeneration of irradiation-induced salivary gland damage. PLoS One 2013; 8: e71167. 10.1371/journal.pone.0071167LimJYRaJCShinISJangYHAnHYChoiJSSystemic transplantation of human adipose tissue-derived mesenchymal stem cells for the regeneration of irradiation-induced salivary gland damagePLoS One20138e7116710.1371/journal.pone.0071167Open DOISearch in Google Scholar
Gültekin SS, Sahmaran T. The efficacy of patient-dependent practices on exposure rate in patients undergoing iodine-131 ablation. Health Phys 2013; 104: 454-8. 10.1097/HP.0b013e318283f853GültekinSSSahmaranTThe efficacy of patient-dependent practices on exposure rate in patients undergoing iodine-131 ablationHealth Phys2013104454810.1097/HP.0b013e318283f853Open DOISearch in Google Scholar
